WINDTREE THERAPEUTICS INC /DE/ (WINT) SEC Filings & Financial Intelligence
WINDTREE THERAPEUTICS INC /DE/ (WINT) is a publicly traded company on the OTC, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: WINT
CIK: 946486
Exchange: OTC
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
EisnerAmper LLP
Auditor SinceSince 12/31/2022 12:00:00 AM
Lead Engagement PartnerPatrick Boyle
Audit LocationPhiladelphia, Pennsylvania, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-07-22 | 2025-12-23 | FORM 8-K | 0001437749-26-024009 | View SEC Doc Filr Page |
| NT 10-K | 2026-04-01 | 2025-12-31 | FORM NT 10-K | 0001437749-26-010838 | View SEC Doc Filr Page |
| 8-K | 2026-01-07 | 2026-01-05 | FORM 8-K | 0001437749-26-000805 | View SEC Doc Filr Page |
| 8-K | 2025-12-02 | 2025-11-25 | FORM 8-K | 0001437749-25-036665 | View SEC Doc Filr Page |
| 424B3 | 2025-11-21 | — | FORM 424B3 | 0001437749-25-035907 | View SEC Doc Filr Page |
| 10-Q | 2025-11-19 | 2025-09-30 | FORM 10-Q | 0001437749-25-035751 | View SEC Doc Filr Page |
| NT 10-Q | 2025-11-14 | 2025-09-30 | FORM NT 10-Q | 0001437749-25-035192 | View SEC Doc Filr Page |
| 424B3 | 2025-11-13 | — | FORM 424B3 | 0001437749-25-034620 | View SEC Doc Filr Page |
| S-1 | 2025-10-24 | — | FORM S-1 | 0001437749-25-031723 | View SEC Doc Filr Page |
| 8-K | 2025-10-16 | 2025-10-09 | FORM 8-K | 0001437749-25-031178 | View SEC Doc Filr Page |
| 8-K | 2025-10-06 | 2025-10-06 | FORM 8-K | 0001437749-25-030516 | View SEC Doc Filr Page |
| 8-K | 2025-09-08 | 2025-09-02 | FORM 8-K | 0001437749-25-028578 | View SEC Doc Filr Page |
| 8-K | 2025-09-02 | 2025-08-28 | FORM 8-K | 0001437749-25-028170 | View SEC Doc Filr Page |
| 8-K | 2025-08-20 | 2025-08-19 | FORM 8-K | 0001437749-25-027421 | View SEC Doc Filr Page |
| 10-Q | 2025-08-19 | 2025-06-30 | FORM 10-Q | 0001437749-25-027382 | View SEC Doc Filr Page |
| NT 10-Q | 2025-08-14 | 2025-06-30 | FORM NT 10-Q | 0001437749-25-027000 | View SEC Doc Filr Page |
| ARS | 2025-08-11 | 2024-12-31 | ARS | 0001437749-25-025936 | View SEC Doc Filr Page |
| DEF 14A | 2025-08-08 | 2025-08-28 | FORM DEF 14A | 0001437749-25-025767 | View SEC Doc Filr Page |
| 8-K | 2025-08-08 | 2025-08-04 | FORM 8-K | 0001437749-25-025762 | View SEC Doc Filr Page |
| 3 | 2025-08-05 | 2025-08-03 | FORM 3 | 0001437749-25-024877 | View SEC Doc Filr Page |
| 8-K | 2025-08-05 | 2025-08-05 | FORM 8-K | 0001437749-25-024720 | View SEC Doc Filr Page |
| 8-K | 2025-08-04 | 2025-07-29 | FORM 8-K | 0001437749-25-024625 | View SEC Doc Filr Page |
| PRE 14A | 2025-07-30 | 2025-08-28 | FORM PRE 14A | 0001437749-25-023806 | View SEC Doc Filr Page |
| 8-K | 2025-07-24 | 2025-07-23 | FORM 8-K | 0001437749-25-023352 | View SEC Doc Filr Page |
| 8-K | 2025-07-17 | 2025-07-16 | FORM 8-K | 0001437749-25-022890 | View SEC Doc Filr Page |